期刊文献+

抗肿瘤活性海洋放线菌的筛选及菌株HGF26的初步鉴定 被引量:4

Screening of Antitumor Active Marine Actinomycete and the Initial Characterization of Strain HGF26
下载PDF
导出
摘要 对采自连云港海域的海泥样品进行放线菌选择性分离,用其发酵液进行抗肿瘤活性筛选,并对活性较好的菌株HGF26进行了初步鉴定。从海泥样品中共分离得到放线菌78株,以人肝癌细胞HepG2为靶标,活性筛选得到细胞毒活性达60%以上的阳性菌株3株,以其他5株肿瘤细胞为靶标的复筛表明,菌株HGF、26的发酵液对多种肿瘤细胞具有显著的细胞毒活性,其中对胃癌细胞BGC823的细胞毒活性为79%,活性产物具有较好的酸碱和热稳定性。通过对菌株的培养特征、形态特征、生理生化特征和细胞壁成分分析,将菌株HGF26初步鉴定为微白黄链霉菌的海洋变种。 Actinomycete selective isolation was carried out with marine mud samples collected from sea area in Lianynngang, a screening for antitnmor activity with their fermentation broth, and a better strain in the antitumor activity HGF26 was initially characterized. Altogether 78 strains were isolated from the mud samples, 3 positive of them were screened to have over 60% of cytotoxic activity taking human hepatoma cell HepG2 as a target; it was also indicated by re-screening with another five strains tumor cell that fermentation broth of strain HGF26 had a strong cytoxic activity against many kinds of tumor cell, the cytotoxic activity against gastric carcinoma cell BGC823 was as high as 79% , and the active product having acid-and-alkaline and heat stability. It was characterized that HGF26 as Streptomyces albidoflavas var. marinus through culture, morphological, physiological and biochemical features, and cell wall component analysis.
出处 《微生物学杂志》 CAS CSCD 2009年第5期85-88,共4页 Journal of Microbiology
基金 江苏省海洋资源开发研究院基金项目(JSIMR09A04) 淮海工学院自然科学基金项目(KX07031)
关键词 海洋放线菌 抗肿瘤活性 筛选 菌种鉴定 marine aetinomyeete antitumor activity screening strain characterization
  • 相关文献

参考文献7

二级参考文献16

  • 1叶亮,林亲雄,王海燕,戴俊峰,苏媛,奚涛.具有抗肿瘤活性的海洋链霉菌WBF7发酵条件的初步研究[J].中国海洋药物,2007,26(2):34-37. 被引量:2
  • 2王平.测定放线菌菌体中氨基酸和单糖的快速方法-薄层层析法.微生物学通报,1986,13:228-230. 被引量:57
  • 3Lechevalier MP, Lechevalier HA. Chemical composition as a criterion in the classification of aerobic actinomycetes[J]. Int J Syst Bacteriol, 1970,20:435. 被引量:1
  • 4Chun J, Goodfellow M. A phylogenetic analysis of the genus Nocardia with 16S rRNA gene sequences[J]. Int J Syst Bacteriol, 1995,45(2) :240. 被引量:1
  • 5Newman DJ, Cragg GM. Marine natural products and related compounds in clinical and advanced preclinical trials[J]. J Nat Prod, 2004, 67(8): 1216. 被引量:1
  • 6Peter P, Edrada-Ebel R, Ebel R. Drugs from thesea-Opportunities and Obstacles[J]. Marine Drugs,2003,1:5. 被引量:1
  • 7Jensen PR, Fenical W. Marine microorganisms and drug discovery: current status and future potential[A]. In: Fusetani N,ed Drug from the Sea[M]. Basel, Karger,2000: 6. 被引量:1
  • 8Shirling E B, Gottlieb D. Methods for characterization of streptomyces species [J]. Int J Syst Bacteriol, 1966,16:313. 被引量:1
  • 9Waksman SA. Classification, identification and description of genera and species[A]. In The Actinomycetes [M]. Vol. Ⅱ. Baltimore:The Williams and Wilkins, Co. 1961:328. 被引量:1
  • 10Bewley C A,Faulkner D J. Lithistid sponges: star performers or hosts to the stars[ J]. Angewandte Chemie-International Edition,1998,37: 2 162-2 178. 被引量:1

共引文献66

同被引文献48

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部